Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) combines selective tumor targeting, masking, and validated linker technology with ...

'Harry Potter' audiobook: Iwan Rheon and Blake Harrison on finding Lupin's werewolf howl, Pettigrew's mouse voice and almost playing Dobby

Iwan Rheon (“Game of Thrones”) and Blake Harrison (“The Inbetweeners”) are the new Moony and Wormtail in Audible’s “Harry ...
Zacks.com on MSN

Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know

Werewolf Therapeutics (HOWL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Seeking Alpha

Werewolf Therapeutics: Still In The Race To Develop Next Generation Cytokines

HOWL reported interim data in November from its phase 1/1b trial of WTX-124 in solid tumors. There are signs of antitumor activity at the 12 mg dose of WTX-124, with two unconfirmed partial responses ...
Nasdaq

Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...
Nasdaq

Werewolf (HOWL) Up on Deal With Merck for Solid Tumor Study

Werewolf Therapeutics, Inc. HOWL announced that it has entered into a collaboration and supply agreement with pharma giant Merck MRK to evaluate its lead pipeline candidate, WTX-124, in combination ...